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ABSTRACT 38 
Nosema ceranae is a new and emerging microsporidian parasite of European honey 39 
bees, Apis mellifera that has been implicated in colony losses worldwide. RNA 40 
interference (RNAi), a post-transcriptional gene silencing mechanism, has emerged as 41 
a potent and specific strategy for controlling infections of parasites and pathogens in 42 
honey bees. While previous studies have focused on the silencing of parasite/pathogen 43 
virulence factors, here we explore the possibility of silencing a host factor as a 44 
mechanism for reducing parasite load. Specifically, we use an RNAi strategy to 45 
reduce the expression of a honey bee gene, naked cuticle (nkd) which is a negative 46 
regulator of host immune function. Our studies found that nkd mRNA levels in adult 47 
bees were upregulated by N. ceranae infection (and thus the parasite may use this 48 
mechanism to suppress host immune function), and ingestion of dsRNA specific to 49 
nkd efficiently silenced its expression. Furthermore, we found that RNAi-mediated 50 
knockdown of nkd transcripts in Nosema-infected bees resulted in upregulation of 51 
expression of several immune genes (Abaecin, Apidaecin, Defensin-1, and PGRP-S2), 52 
reduction of Nosema spore loads, and extension of honey bee lifespan. The results of 53 
our studies clearly indicate that silencing the host nkd gene can activate honey bee 54 
immune responses, suppress the reproduction of N. ceranae and improve the overall 55 
health of honey bees. This study represents a novel host-derived therapeutic for honey 56 
bee disease treatment that merits further exploration. 57 
IMPORTANCE 58 
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Given the critical role of honey bees in the pollination of agricultural crops, it is 59 
urgent to develop strategies to prevent the colony decline induced by the infection of 60 
parasites/pathogens. Targeting parasites and pathogens directly by RNAi has been 61 
proved to be useful for controlling infections in honey bees but little is known about 62 
the disease impacts of RNAi silencing of host factors. Here, we demonstrate that 63 
knocking down the gene encoding the honey bee immune repressor nkd can suppress 64 
the reproduction of N. ceranae and improve the overall health of honey bees, which 65 
highlights the potential role of host-derived and RNAi-based therapeutics in 66 
controlling the infections in honey bees. The information obtained from this study 67 
will have positive implications for honey bee disease management practices.  68 
 69 
  70 
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Honey bees, Apis mellifera, play a critical role in pollination of important crops. 71 
However, the honey bee populations have suffered high losses in much of the world 72 
(1), coincident with an increase in agricultural demand for honey bee pollination (2). 73 
Specifically, honey bee colony losses in the United States have been exacerbated 74 
since the report of Colony Collapse Disorder (CCD), a syndrome that describes 75 
large-scale, unexplained losses of managed honey bees (3-9). High levels of parasites 76 
and pathogens have been linked to the decline of honey bee colonies (10, 11). 77 
Nosema is a genus of obligate, intracellular microsporidian parasites, which infects 78 
many diverse animal species, including honey bees (12, 13). For years, Nosema 79 
disease of European honey bees was exclusively attributed to a single Nosema species 80 
- Nosema apis. Another species N. ceranae was originally detected in Asian honey 81 
bees, A. cerana (14), and subsequently found to infect European honey bees, A. 82 
mellifera (15, 16). Since then, the infection of A. mellifera by N. ceranae has been 83 
reported worldwide (17-20), and nosemosis of A. mellifera caused by N. ceranae is 84 
now far more prevalent than that by its native sympatric congener N. apis (17, 21-25). 85 
Although there are no outward disease symptoms reported (12), N. ceranae infection 86 
can cause worker bee energetic stress and behavioral changes (26-29), leading to 87 
reduced lifespan of infected bees. As an emerging parasite, N. ceranae has often been 88 
linked to colony losses worldwide. A study based on Spanish honey bee populations 89 
showed that natural infection by N. ceranae could cause colony collapse (30, 31). 90 
New evidence has shown that N. ceranae synergistically interacts with pesticides, 91 
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resulting in more complex and severe diseases in honey bees (32-35). So far, the only 92 
registered treatment for nosemosis in North America is fumagillin. With prolonged 93 
use of fumagillin, the issues of drug resistance have arisen (36). As a result, novel 94 
parasite-specific and environmentally friendly therapeutic options are urgently needed 95 
for Nosema treatment.  96 
RNA interference (RNAi), a post-transcriptional gene silencing mechanism, is an 97 
efficient and specific method of gene silencing which functions by inducing 98 
degradation of homologous mRNAs (37, 38). RNAi technology has been explored to 99 
protect honey bees from infection by pathogens and parasites (39). Three honey bee 100 
viruses, Israeli acute paralysis virus (IAPV), Deformed wing virus (DWV), and 101 
Chinese sacbrood virus (CSBV) have been successfully inhibited by RNAi under 102 
laboratory conditions by feeding bees with virus-specific dsRNAs/siRNAs (40-43). 103 
Moreover, a large-scale field application of IAPV dsRNA improved bee survival, 104 
colony size and honey yield (44). RNAi has also been used to help control the 105 
parasitic mite Varroa destructor (45). In one previous study, N. ceranae ADP/ATP 106 
transporter genes were targeted and silenced by corresponding dsRNAs, resulting in 107 
the decline of spore loads and alleviation of diseases in infected bees (46). 108 
All honey bee disease applications of RNAi to date have targeted the genes of 109 
parasites or pathogens. Nevertheless, disease always involves interactions between 110 
hosts and parasites/pathogens, and it is also possible to mitigate infections from the 111 
host perspective, i.e. to use RNAi to manipulate host factors that interact with 112 
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parasites or pathogens. In fact, Nosema infection dramatically alters honey bee 113 
transcriptional responses (47-49), providing potential targets for host-based RNAi 114 
manipulation.  115 
The Wnt signaling pathway is an important regulator of immune function in 116 
mammals (50), and recently has been found to function in regulating immune 117 
pathways, specifically Toll pathways, in insects (Drosophila) (51). There are several 118 
genes that serve as antagonists of the Wnt pathway and thus upregulated expression of 119 
these genes should suppress immune function. One of these genes has been found in 120 
Drosophila - the naked cuticle gene (52). As suppressors of immune function, these 121 
may serve as excellent targets for parasite manipulation of the hosts' transcriptional 122 
pathways - if they parasite can up-regulate these antagonists, it can suppress the hosts 123 
immune response. In light of the fact that nkd is a negative regulator of Wnt signaling 124 
pathway, we hypothesized that nkd expression might be regulated by Nosema 125 
infection and thereby could serve as a potential target of RNAi to mitigate the Nosema 126 
infection in honey bees. Here we confirmed nkd mRNA levels were upregulated when 127 
bees were infected by N. ceranae. Our RNAi experiments showed that silencing nkd 128 
led to the enhancement of immune responses through increased immune gene 129 
expression, reduction in parasite spore load, and improvement in life expectancy of N. 130 
ceranae infected bees. We provide unequivocal evidence that silencing the nkd gene is 131 
an efficient way to control N. ceranae infection and improve honey bee health. 132 
 133 
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METHODS AND MATERIALS 134 
Honey bees. Honey bees used in this study were collected from colonies of Apis 135 
mellifera ligustica maintained at the USDA-ARS Bee Research Laboratory, Beltsville 136 
Maryland. Newly emerged bees were obtained by removing honeycomb frames with 137 
sealed brood from strong and healthy colonies that were identified to be 138 
Nosema-negative, placing the frames into mesh-walled cages individually, and then 139 
maintaining the frames in an insect growth chamber at 34±1°C, 55±5% RH overnight. 140 
Emerging adult worker bees were collected the next day (< 24 hrs). In order to make 141 
sure that the experimental bees were free of N. ceranae infection before proceeding to 142 
the experimental inoculation, we confirmed the negative status of Nosema infection 143 
using a hemocytometer and light microscopy. Briefly, 30 abdomens of newly emerged 144 
bees were dissected and ground up thoroughly in 30 ml of deionized H2O. 10 μl of the 145 
homogenate was loaded onto a hemocytometer and the presence of spores was 146 
determined under light microscopy following a previously described method (53).  147 
Inoculum preparation. N. ceranae spores were purified from foragers collected 148 
outside the entrance of identified N. ceranae infected colonies. Midguts were pulled 149 
out and homogenized in sterile, distilled water. The purification of Nosema spores 150 
from the homogenate was performed as described by Fries et al. (2013) (54). The 151 
homogenate was filtered through a nylon mesh cloth (65 μm pore size) by 152 
centrifuging it for 5 minutes at 3,000 g. The supernatant was discarded and the pellet 153 
resuspended in sterile water and centrifuged for 10 min at 5,000 g, this step was 154 
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repeated twice. Finally, the pellet was resuspended in dH2O and stored at room 155 
temperature for no more than one week. The inoculum was obtained by diluting the 156 
spore solution with sucrose solution, with a final concentration of 2.0 × 107 spores/ml 157 
in 50% (m/V) sucrose solution.  158 
Inoculation. The newly emerged bees were collected and starved for 3 hrs in an 159 
incubator (32°C, 75% RH) before inoculation with Nosema spores in solution. 160 
Individual feeding was performed for each bee by holding two wings of a bee on each 161 
side with one hand and feeding the bee with 5 μl inoculum (100,000 spores) with a 162 
pipette with the other hand. 30 bees were then distributed into each cup cage, which is 163 
a plastic bee-rearing cup with a top-feeder design (55). A 3 ml syringe filled with 50% 164 
(m/V) sucrose solution was inserted in the top of the cage to feed the bees and the 165 
solution was changed every three days. A small pollen patty was supplied in the 166 
bottom of the cage for 6 days. The same number of control bees (without spore 167 
inoculation) were transferred into a cup cage as well. There were 4 replicates for each 168 
group. All cup cages were maintained in an incubator (32°C, 75% RH). Five bees 169 
were sampled from each cage at 6 days, 9 days, 12 days, 15 days, and 18 days post 170 
inoculation, respectively. The collected bee samples were immediately put into -80°C 171 
and stored until processing.  172 
Production of dsRNA. Primers were designed from the sequence of the A. 173 
mellifera nkd gene (GenBank accession no. XM_001120899) by using the E-RNAi 174 
web service (56), and primers for GFP that served as the control gene were used from 175 
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previous studies (57). All primer sequences were fused with the T7 promoter 176 
sequence (underlined; see Table 1). PCR reactions were performed using different 177 
templates individually: the cDNA of an adult bee was used for the amplification of 178 
nkd, and the pGFP vector (Clontech) was used for that of GFP. The 100 μl PCR 179 
reaction mixture contained the following: 78μl H2O, 10μl 10× reaction buffer 180 
(Invitrogen), 3μl MgCl2, 2μl dNTP mix (10 mM; Invitrogen), 2μl forward primer (20 181 
μM), 2μl reverse primer (20 μM), 1μl Taq polymerase (Invitrogen), and 2μl DNA 182 
template. The PCR program was 94°C for 3min, followed by 35 cycles of 94°C for 183 
30s, 56°C for 30s and 72°C for 90s, and 72°C for 10 min. After each PCR 184 
amplification, the products were then verified in 1.0% agarose gels, purified, and then 185 
used as the templates for the in vitro transcription reaction. The production of dsRNAs 186 
was carried out by using the MEGAscript RNAi Kit (Ambion). The transcription 187 
reactions were assembled according to the manufacturer’s instruction, and the time of 188 
incubation at 37°C was extended to 15hrs. The following steps such as nuclease 189 
digestion, purification, and elution were performed using the materials associated with 190 
the kit. The quality of the dsRNAs was tested using 1.0% agarose gels and their 191 
concentration was determined with a Nanodrop 8000 spectrophotometer (Thermo 192 
Fisher Scientific Inc.). The products were diluted with sucrose solution to final 193 
concentrations of 10μg/ml, 20μg/ml, and 40μg/ml dsRNA in 50% (m/V) sucrose 194 
solution, respectively. The final solutions were stored at -80°C until use. 195 
RNA interference treatment. Before the RNAi treatment, the newly-emerged bees 196 
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were collected and inoculated with N. ceranae spores as described above, and then 197 
transferred into bee rearing cages. In each cage, 20 bees were supplied with 1.5ml of 198 
50% sucrose solution containing nkd or GFP dsRNA in a 3 ml syringe and a small 199 
pollen patty in the bottom of the cage at the same day. Bees were fed with the dsRNA 200 
for 15 days; feedings were changed daily. The pollen patty was supplied for the first 201 
six days and changed every three days. All cages were incubated at 32°C, 75% RH, 202 
and the dead bees were removed every day.  203 
To test the efficiency of gene knockdown, three different concentrations of nkd 204 
dsRNA solution, 10μg/ml, 20μg/ml, and 40μg/ml, were applied to separate cages, and 205 
20μg/ml GFP dsRNA solution was used for control bees. There were three replicates 206 
for each treatment. The bees were sampled at 9 days (D9) and 15 days (D15) post the 207 
ingestion of dsRNAs and stored at -80 °C until use.  208 
To study the biological responses to the knockdown of nkd, 20μg/ml of nkd dsRNA 209 
and GFP dsRNA were fed to the infected bees. Another control group was set up with 210 
bees without any treatment and fed only 50% sucrose solution and pollen. Each group 211 
contained three replicates. The number of dead bees was recorded daily and were then 212 
removed. All the bees were collected at D15 and stored at -80 °C until use. 213 
Spore counting. To evaluate the Nosema infection levels of the RNAi-treated bees, 214 
the number of spores were counted in individual bees. First, the abdomens were 215 
separated, put into 1.5ml Eppendorf tubes individually, and homogenized thoroughly 216 
in 1ml dH2O using a pestle. Then each homogenate was diluted 100 times. 10 μl of 217 
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the diluted solution was loaded onto a hemocytometer and the number of spores was 218 
counted under light microscopy as described by Cantwell, 1970 (53). The spore load 219 
was obtained using the following formula, (spore counts × diluted times) / 20.  220 
RNA extraction and cDNA synthesis. TRIzol reagent (Invitrogen) was used to 221 
extract total RNA from the abdomen of individual bees following the manufacturer’s 222 
protocols. Any genomic DNA contamination was removed by treatment with DNase I 223 
(DNA-free kit, Ambion). The purity and quantity of RNA samples were examined by 224 
using a Nanodrop 8000 spectrophotometer (Thermo Fisher Scientific Inc.). All RNAs 225 
were stored at -80°C until use. First-strand cDNA was produced from a 20-μl 226 
reverse-transcriptional reaction mixture which contained 2 μl total RNA 227 
(approximately 1μg/μl), 1 μl dNTP mix (10 mM), 1 μl random primers (0.15 μg/μl), 1 228 
μl DTT (0.1 M), 4 μl 5×First-Strand Buffer, 1 μl SuperScript III RT (200 U/μl, 229 
Invitrogen), and 10 μl Nuclease-free water. The reaction program was as follows: 230 
25°C for 5 min, 50°C for 45 min followed by 70°C for 15 min. The cDNAs were 231 
stored at -20°C until use. 232 
Quantitative PCR. Quantitative PCR (qPCR) was run on a CFX384 Touch 233 
Real-Time PCR System (Bio-Rad, Hercules, CA), and SYBR Green was selected as 234 
the detection signal. Primers used here were designed with Primer3 (58) (Table 1). 235 
β-actin served as the reference gene and all primer pairs were validated as described 236 
by (59). Each 10 µl PCR reaction was assembled by mixing 5 µl 2× Brilliant III 237 
Ultra-Fast SYBR Green QPCR Mix (Stratagene, La Jolla, CA), 0.25 µl forward 238 
12 
 
primer (20 mM), 0.25 µl reverse primer (20 mM), 0.5 µl cDNA, and 4 µl 239 
nuclease-free water. Each reaction was run in duplicate. The PCR program was 95°C 240 
for 3 min, followed by 40 cycles of 95°C for 10 s, 60°C for 45 s. Melting curves and 241 
no template control (NTC) reactions were monitored to evaluate the quality and 242 
specificity of amplification. Only a single peak was seen in all melting curves and no 243 
peaks showed in the NTCs. PCR products were run on a 1% agarose gel to confirm 244 
the expected amplification sizes. The threshold cycle values (Ct) were generated by 245 
the CFX Manager 3.1 (Bio-Rad). The relative quantification of gene expression was 246 
calculated with the comparative Ct method (ΔΔCt Method) (60). For each gene, the 247 
average Ct value of the target was normalized with the corresponding β-actin 248 
following the formula: ΔCt = (Average Cttarget) – (Average Ctβ-actin), and the group of 249 
bees with the lowest level of gene expression was chosen as a calibrator (ΔCtcalibrator). 250 
The ΔCt value of each group was subtracted from the ΔCtcalibrator to generate ΔΔCt. 251 
The concentration of each target in each group was calculated using the formula 252 
2-(ΔΔCt), and expressed as an n-fold difference relative to the calibrator. 253 
Bioinformatic and statistical analyses. Multiple alignments of insect nkd protein 254 
sequences was carried out with ClustalX 2.0 (61). Protein domain identification and 255 
secondary structure prediction of A. mellifera nkd were respectively performed with 256 
the InterProScan tool and EMBOSS: garnier algorithm of Geneious v9.1.3 257 
(Biomatters; available from www.geneious.com).  258 
  Dynamics of nkd gene expression during the course of Nosema infection, immune 259 
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gene expression, and spore load of infected bees after RNAi treatment were analyzed 260 
using independent samples t-tests. mRNA levels of nkd after dsRNA treatment were 261 
analyzed by one-way ANOVA with all compared groups passing an equal variance 262 
test, and the post-hoc effects were determined using Tukey HSD tests. Survival 263 
analysis was performed using the Kaplan-Meier method, and log-rank and Wilcoxon 264 
tests were computed to assess the overall homogeneity between the treatment strata. 265 
Pairwise comparisons were carried out using Wilcoxon tests. In all cases, P < 0.05 266 
was taken to be significant. All analyses were carried out by PASW Statistics 18 267 
(SPSS Inc.). 268 
 269 
RESULTS 270 
Identification of a highly conserved nkd gene in honey bees. The identified honey 271 
bee nkd gene encodes a predicted protein of 545 aa, which shares 92.9% and 89.2% 272 
sequence identity with the bumble bee Bombus impatiens and stingless bee Melipona 273 
quadrifasciata, respectively (Fig. 1). This protein is highly conserved in Hymenoptera, 274 
as remarkable sequence identity is also seen in non-Apidae species, ranging from 65.5% 275 
(Camponotus floridanus) to 85.8% (Megachile rotundata) (Fig. 1). A conserved 276 
EF-hand domain (InterPro ID: IPR002048) - which is known to bind calcium - was 277 
identified in the nkd proteins (Fig. 1). Additional conserved regions included a region 278 
responsible for interaction with Dishevelled (Dsh), a component of the Wnt signaling 279 
pathway (62), and the nuclear localization motif required for nuclear localization and 280 
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inhibition of Wnt signaling (63) (Fig. 1). Although the diversity of nkd protein 281 
sequences dramatically increases when expanding the comparison to different insect 282 
orders, the sequence features mentioned above are still highly conserved. (Fig. S1)  283 
N. ceranae infection up-regulates the expression of nkd gene. As shown in Fig. 2, 284 
the dynamics of the nkd gene expression was altered during the N. ceranae infection. 285 
The expression of nkd in the infected bees was significantly upregulated compared 286 
with that of control bees at Day 6 (D6) and Day 18 (D18) post inoculation (Fig. 2. for 287 
D6, t-test: t = -2.774, df = 9, P = 0.022; for D18, t-test: t = -3.387, df = 10.860, P = 288 
0.006). Collectively, N. ceranae infection upregulated the nkd gene expression (t-test: 289 
t = -2.872, df = 63, P = 0.006). 290 
Ingestion of dsRNA silences the nkd gene expression in N. ceranae infected 291 
bees. As it is shown in Fig. 3, 9 days feeding of nkd dsRNA was insufficient to reduce 292 
the mRNA levels of the target gene in adult bees (ANOVA: F1,11 = 0.442, P = 0.742), 293 
but the gene expression can be significantly silenced by 15 days ingestion of the 294 
corresponding dsRNA (ANOVA: F1,11 = 9.1781, P = 0.005). Moreover, the 295 
knockdown of nkd exhibited a dosage-dependent manner (Fig. 3): along with the 296 
increase of dsRNA concentration, the effect of gene silencing also increased. When 10 297 
μg/ml of dsRNA was applied, a 40% knockdown of nkd mRNA was achieved, while 298 
higher amounts of 20 or 40 μg/ml dsRNA resulted in 50% and 70% gene silencing, 299 
and the differences compared to controls became significant (Fig. 3. P = 0.018 for 20 300 
μg/ml; P = 0.004 for 40 μg/ml). 301 
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Silencing of the nkd gene up-regulates immune gene expression in N. ceranae 302 
infected bees. As shown in Fig. 4, the nkd-silenced bees expressed significantly 303 
higher amounts of mRNA for three antimicrobial peptide (AMP) genes Abaecin, 304 
Apidaecin, and Defensin-1 relative to the control bees (Fig. 4. t-test: for Abaecin, t = 305 
-3.689, df = 9, P = 0.005; for Apidaecin, t = -3.047, df = 4.982, P = 0.029; for 306 
Defensin-1, t = -2.855, df = 9, P = 0.019). Moreover, the expression of a 307 
peptidoglycan recognition protein (PGRP) gene, PGRP-S2 was also significantly 308 
up-regulated in nkd-silenced bees compared with the control bees (Fig. 4. t-test, t = 309 
-3.183, df = 5.043, P = 0.024). 310 
Silencing of the nkd gene reduces the Nosema spore levels and extends the 311 
lifespan of N. ceranae infected bees. After feeding with nkd dsRNA, the spore load 312 
of infected bees was significantly (approximately 50%) lower than controls (fed with 313 
GFP dsRNA) (Fig. 5. t-test: t = 2.458, df = 15.485, P = 0.026), indicating that 314 
knockdown of the nkd gene expression results in a decrease in Nosema infection 315 
levels. Survival analysis was performed to further examine the effect of silencing the 316 
nkd gene on the lifespan of honey bees after Nosema infection. The survival 317 
distributions for the tested groups were significantly different (Fig 6. log-rank test: χ2 318 
= 24.472, df = 2, P < 0.001; Wilcoxon test: χ2 = 25.020, df = 2, P < 0.001). A Nosema 319 
infection indeed induced higher mortality in the infected honey bees (Fig 6. No 320 
treatment vs GFP-dsRNA: Wilcoxon test, χ2 = 25.218, P < 0.001), however, silencing 321 
of nkd significantly reduced the incidence of death of adult bees (Fig 6. nkd-dsRNA 322 
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vs GFP-dsRNA: Wilcoxon test, χ2 = 4.165, P = 0.041).  323 
 324 
DISCUSSION 325 
Significant progress has been made in exploring RNAi as a therapeutic strategy for 326 
controlling diseases in honey bees, with much attention focused on pathogen-specific 327 
virulence determinants. Nosema are obligate intracellular parasites and therefore 328 
require host cell proteins and pathways to support their replication and many phases 329 
of their lifecycles (12, 13). In the present study, the identification and characterization 330 
of a host-based factor that is required for parasite pathogenesis in hosts allow us to 331 
obtain important insights into the host-parasite interactions and to propose a potential 332 
drug target against the parasite.  333 
Wnt signaling is an evolutionarily conserved pathway that plays a critical role in 334 
embryogenesis, cell proliferation and differentiation (64). Additionally, recent studies 335 
found that activation of the Wnt signaling pathway regulates the immune response to 336 
certain pathogenic bacterial infections by up-regulating the expression of 337 
anti-inflammatory factors and down-regulating the expression of inflammatory factors 338 
(65-68). nkd is linked to Wnt signaling and was originally found to act as an inducible 339 
antagonist of Wnt signaling during embryonic development in Drosophila (52). The 340 
results of our study confirmed our hypothesis that nkd and Wnt signaling might be 341 
also involved in the honey bee responses to infections of Nosema. Indeed, Nosema 342 
infection can result in dramatic host transcriptional responses (47-49), and the 343 
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expression of nkd gene is significantly upregulated during the N. ceranae infection in 344 
honey bees, suggesting that nkd and Wnt signaling might be targeted by N. ceranae 345 
during the infection process to alter the defensive function of hosts. 346 
Knockdown of nkd by feeding Nosema-infected bees with dsRNA specific to nkd 347 
led to several remarkable alternations, one of which was the modulation of host 348 
immune responses. Previous studies have revealed that N. ceranae infection induces 349 
immunosuppression in honey bees by down-regulating several immune genes such as 350 
AMP genes, Apidaecin, Abaecin, Defensin-1, and, Hymenoptaecin (69, 70). Our 351 
results show that silencing the nkd gene in bees infected with N. ceranae can reverse 352 
immune suppression and enhance the host immune response. The exact mechanism of 353 
host immune induction by nkd silencing remains unclear. However, silencing of the 354 
nkd gene ultimately reduces the Nosema infection levels and extends the lifespan of 355 
infected adult bees. 356 
Since infection always involves the interaction between host and parasite/pathogen, 357 
infections can theoretically be controlled by targeting the host of the 358 
parasite/pathogen. All previous gene-based efforts to control honey bee parasites or 359 
pathogens have targeted these biotic threats directly. Here, by targeting the honey bee 360 
nkd gene with RNAi, we demonstrate that silencing a honey bee gene can suppress 361 
the reproduction of parasites/pathogens and improve the overall health of honey bees. 362 
Our results provide a novel host-derived strategy to mitigate honey bee disease. 363 
Similar studies have been reported in various species. For example, silencing of the 364 
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Cactus gene, an inhibitor of Toll pathway, reduces the extent of dengue virus infection 365 
in the midgut by 4 fold in the mosquitos, Aedes aegypti (71). Down-regulation of 366 
scavenger receptor class B type 1 (SR-B1) expression by RNAi dramatically 367 
decreases the susceptibility of human hepatoma cells to Hepatitis C virus (HCC) 368 
infection, resulting in the inhibition of this virus infection (72). These studies together 369 
indicate that targeting host factors by RNAi can potentially prevent the hosts from 370 
infections of parasites/pathogens and promote the overall health of hosts. 371 
RNAi technology has great potential for relieving the impacts of honey bee 372 
diseases. Other previous studies (46), combined with our efforts, demonstrate that 373 
silencing the parasite/host genes by RNAi manipulation is efficient to suppress 374 
parasite development and improve honey bee health to some extent in the laboratory. 375 
It is likely that the combination of both strategies, meaning targeting both host and 376 
parasite genes in the same RNAi manipulation, will lead to better results for 377 
controlling Nosema infection. As for field application, more experiments are needed 378 
to determine ideal treatment time, the suitable concentration of dsRNA, and other 379 
factors. This present study will help direct the application of RNAi to mitigate N. 380 
ceranae infection in honey bees. 381 
In sum, these studies have identified a host factor required for Nosema infection 382 
and highlight the potency of host-derived RNAi-based therapeutics to inhibit not only 383 
microsporidian parasite infection but also potentially a wide range of pathogens and 384 
parasites that cause serious diseases in honey bees. 385 
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TABLES 631 
TABLE 1 Primer sequences used in this study. 632 
 Gene (accession 
no.) 
Primer Sequence (5’→3’) Amplicon 
location 
Amplicon 
length (bp) 
Reference 
RNAi nkd 
(XM_001120899) 
nkd-RNAi-F 
 
nkd-RNAi-R 
taatacgactcactatagggcgaCGC
GCTTATGTTCAACCTC 
taatacgactcactatagggcgaGGTC
GCGTGTTTCAAATGAT 
1889-2122 234 This study 
 GFP  
(AF324407) 
GFP- RNAi -F 
 
GFP- RNAi-R 
taatacgactcactatagggcgaTTCC
ATGGCCAACACTTGTCA 
taatacgactcactatagggcgaTCAA
GAAGGACCATGTGGTC 
173-674 502 (57) 
qPCR nkd nkd-F 
 
nkd-R 
AGGATGACGGTGAAAAT
GCG 
ATTAGTCGTGAGGAGAGG
CG 
1365-1540 176 This study 
 β-actin 
(NM_001185145) 
actin-F 
 
actin-R 
TGCCAACACTGTCCTTTC
TG 
AGAATTGACCCACCAATC
CA 
1018-1173 156 (73) 
 Abaecin 
(NM_001011617) 
Abaecin-F 
 
Abaecin-R 
AGATCTGCACACTCGAGG
TCTG 
TCGGATTGAATGGTCCCT
GA 
14-214 201 (74) 
 Apidaecin 
(NM_001011613) 
Apidaecin-F 
 
Apidaecin-R 
TTTTGCCTTAGCAATTCTT
GTTG 
GCAGGTCGAGTAGGCGG
ATCT 
58-137 80 This study 
 Defensin-1 
(NM_001011616) 
Defensin-1-F 
 
Defensin-1-R 
TGTCGGCCTTCTCTTCAT
GG 
TGACCTCCAGCTTTACCC
AAA 
88-288 201 This study 
 PGRP-S2 
(NM_001163716) 
PGRP-S2-F 
 
PGRP-S2-R 
TTGCACAAAATCCTCCGC
C 
CACCCCAACCCTTCTCAT
CT 
146-274 129 This study 
 633 
  634 
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FIGURE LEGENDS 635 
FIG 1 Sequence conservation and predicted secondary structure of A. mellifera nkd. 636 
(A) multiple alignment of A. mellifera (XP_001120899), Bombus impatiens 637 
(XP_012249347), Megachile rotundata (XP_003702467), Melipona quadrifasciata 638 
(KOX70301), Atta colombica (KYM87061), Harpegnathos saltator (XP_011151892), 639 
and Camponotus floridanus (EFN66676) nkd protein sequences. Black and grey 640 
shadings indicate identity and high conservation of amino acids, respectively. The 641 
region responsible for interaction with dsh is indicated with the red bar. The nuclear 642 
localization motif is underlined by the green bar. The blue box highlights the EF-hand 643 
domain. (B) protein domain identification and secondary structure prediction of A. 644 
mellifera nkd. The conserved domain is shown with a black bar.  645 
 646 
FIG 2 The expression profile of nkd during N. ceranae infection. The X axis indicates 647 
the days post inoculation of Nosema spores. The relative gene expression levels (Y 648 
axis) are expressed with mean ± SEM. The sample size is shown in the bottom of each 649 
bar, and the solid five-pointed star indicates the calibrator used to normalize the gene 650 
expression. Data were analyzed by independent samples t-test. Significant differences 651 
between groups are indicated by asterisks (* P< 0.05, ** P< 0.01).  652 
 653 
FIG 3 Knockdown of nkd gene in adult bees by dsRNA ingestion. All groups of adult 654 
bees were inoculated with Nosema spores first and then fed with sucrose solution 655 
34 
 
containing dsRNA for 15 days. The silencing effect was examined after 9 days (A) 656 
and 15 days (B) feeding of dsRNA, respectively. The control bees (GFP-dsRNA) 657 
were fed with the dsRNA derived from GFP sequence. For the treatment groups, three 658 
different concentration gradients of nkd dsRNA were examined. They were as follows, 659 
40 μg/ml (nkd-dsRNA-40), 20 μg/ml (nkd-dsRNA-20), and 10 μg/ml 660 
(nkd-dsRNA-10). The relative gene expression values are shown as mean ± SEM. All 661 
groups are with the same sample size (n = 3). The calibrator used to normalize the 662 
gene expression is indicated with the solid five-pointed star inside the bar. One-way 663 
ANOVA was employed to analyze the differences of data, and post-hoc effects were 664 
identified by Tukey HSD tests. Significant differences between groups are indicated 665 
by asterisks (* P < 0.05, ** P < 0.01). 666 
 667 
FIG 4 Effect of nkd gene silencing on the immune gene expression in Nosema 668 
infected bees. The relative mRNA levels of immune genes (X axis) were compared 669 
between control bees fed with 20 μg/ml GFP dsRNA (GFP-dsRNA, n = 6) and the 670 
treatment bees fed with 20 μg/ml nkd dsRNA (nkd-dsRNA, n = 5). Both groups were 671 
inoculated with Nosema spores before dsRNA feeding. The expression values are 672 
expressed with mean ± SEM. Data were analyzed by independent samples t-test. 673 
Significant differences between groups are indicated by asterisks (* P< 0.05, ** P< 674 
0.01). 675 
 676 
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FIG 5 Effect of nkd gene silencing on the Nosema infection levels in adult bees. The 677 
Nosema infection levels were determined by spore counting. Spore loads of the two 678 
groups of bees were compared, the control bees fed with 20 μg/ml GFP dsRNA (n = 679 
11), and the treatment bees fed with 20 μg/ml nkd dsRNA (n = 8). The values of spore 680 
load are expressed with mean ± SEM. Significant differences of data were analyzed 681 
by independent samples t-test, and indicated with asterisks (* P< 0.05). 682 
 683 
FIG 6 Effect of nkd gene silencing on the lifespan of honey bees infected by N. 684 
ceranae. Survival curves for bees inoculated with 100,000 N. ceranae spores at day 0 685 
(i.e., within 24 h after adult emergence) and fed with 50% (m/V) sucrose solution 686 
containing 20 μg/ml nkd dsRNA (nkd-dsRNA, n = 60) or 20 μg/ml GFP dsRNA 687 
(GFP-dsRNA, n = 60) for 15 days, and for the bees without any treatment and only 688 
fed with 50% sucrose solution (No treatment, n = 60). Knockdown of nkd gene 689 
reduced the incidence of death (P = 0.041 by Wilcoxon test).  690 
 691 
 692 
